8-K//Current report
Adaptimmune Therapeutics PLC 8-K
Accession 0001558370-25-011304
$ADAPCIK 0001621227operating
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 7:37 AM ET
Size
524.0 KB
Accession
0001558370-25-011304
Documents
- 8-Kadap-20250813x8k.htmPrimary
8-K
- EX-99.1adap-20250813xex99d1.htm
EX-99.1
- GRAPHICadap-20250813xex99d1001.jpg
GRAPHIC
- GRAPHICadap-20250813xex99d1002.jpg
GRAPHIC
- EX-101.SCHadap-20250813.xsd
EX-101.SCH
- EX-101.LABadap-20250813_lab.xml
EX-101.LAB
- EX-101.PREadap-20250813_pre.xml
EX-101.PRE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001558370-25-011304-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLadap-20250813x8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeoperating
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001621227
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 7:37 AM ET
- Size
- 524.0 KB